EV/EBITDA
30.94
-0.13-0.42%
Thu, 13 Mar 2025 20:27:41 GMT
Summary
- As of March 14, 2025, SRPT EV/EBITDA is 30.94, with a fall of -0.13 (-0.42%) during the most recent trading day.
- Over the past year, SRPT EV/EBITDA has increased by +58.79 (+211.10%).
- SRPT EV/EBITDA is now -82.10% below its all-time high of 172.82.
Performance
SRPT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SRPT EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.4% | -0.4% | -0.5% |
| 1 m1 month | -9.6% | -9.6% | -9.9% |
| 3 m3 months | -55.3% | -24.3% | -19.9% |
| 6 m6 months | -70.8% | -23.9% | -21.0% |
| ytdytd | -18.5% | -18.5% | -19.0% |
| 1 y1 year | +211.1% | -22.4% | -20.7% |
| 5 y5 years | +366.0% | +28.0% | -1.3% |
SRPT EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.8% | 30.88 | +0.2% | |
| 3 m | 3-month | 71.21 | -56.5% | 30.88 | +0.2% |
| 6 m | 6-month | 108.76 | -71.5% | 30.88 | +0.2% |
| 1 y | 1-year | 172.82 | -82.1% | -28.92 | +207.0% |
| 3 y | 3-year | 172.82 | -82.1% | -31.61 | +197.9% |
| 5 y | 5-year | 172.82 | -82.1% | -31.61 | +197.9% |
| alltime | all time | 172.82 | -82.1% | -149.04 | +120.8% |
Sarepta Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 30.94(-18.5%) |
| 2024 | 37.97(-272.1%) |
| 2023 | -22.06(+8.9%) |
| 2022 | -20.25(-6.6%) |
| 2021 | -21.69(-22.8%) |
| 2020 | -28.10(+92.9%) |
| 2019 | -14.57(-40.9%) |
| 2018 | -24.65(-75.1%) |
| 2017 | -98.93(+1745.7%) |
| 2016 | -5.36(-32.8%) |
| 2015 | -7.98(+95.6%) |
| 2014 | -4.08(-29.3%) |
| 2013 | -5.77(-74.3%) |
| 2012 | -22.43(+1119.0%) |
| Date | Value |
|---|---|
| 2011 | -1.84(-82.6%) |
| 2010 | -10.60(+30.2%) |
| 2009 | -8.14(+240.6%) |
| 2008 | -2.39(+9.1%) |
| 2007 | -2.19(-54.6%) |
| 2006 | -4.82(-47.3%) |
| 2005 | -9.15(+223.3%) |
| 2004 | -2.83(-61.5%) |
| 2003 | -7.35(+44.1%) |
| 2002 | -5.10(-68.8%) |
| 2001 | -16.32(+110.3%) |
| 2000 | -7.76(-25.0%) |
| 1999 | -10.34(+68.1%) |
| 1998 | -6.15(-66.2%) |
| 1997 | -18.19 |
FAQ
- What is Sarepta Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Sarepta Therapeutics?
- What is SRPT EV/EBITDA year-to-date change?
- What is Sarepta Therapeutics EV/EBITDA year-on-year change?
What is Sarepta Therapeutics EV/EBITDA?
The current EV/EBITDA of SRPT is 30.94
What is the all time high EV/EBITDA for Sarepta Therapeutics?
Sarepta Therapeutics all-time high EV/EBITDA is 172.82
What is SRPT EV/EBITDA year-to-date change?
Sarepta Therapeutics EV/EBITDA has changed by -7.03 (-18.51%) since the beginning of the year
What is Sarepta Therapeutics EV/EBITDA year-on-year change?
Over the past year, SRPT EV/EBITDA has changed by +58.79 (+211.10%)